Treatment News : Researchers Hoping to Replicate Case of Functionally Cured Child

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » April 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


April 11, 2013

Researchers Hoping to Replicate Case of Functionally Cured Child

Following on the heels of the case of the Mississippi child apparently functionally cured of HIV, a group of scientists is laying the groundwork for an attempt to replicate the case in other children, Nature Medicine reports. The research team that announced the findings about the child in March will meet with other scientists in May at a retreat of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group, which is sponsored by the National Institutes of Health (NIH). At the retreat, they will strategize study protocols to possibly take children born with HIV off antiretrovirals (ARVs) if they have undetectable viral loads.

Firstly, the researchers hope to launch a pilot study with about two dozen babies born to HIV-positive mothers who did not receive ARVs during pregnancy. They would study risks and benefits of the aggressive ARV treatment the Mississippi baby received shortly after birth.

Meanwhile, researchers also see possibilities in a study presented at the 20th Conference of Retroviruses and Opportunistic Infections (CROI) in Atlanta by Katherine Luzuriaga, MD, from the University of Massachusetts Medical School in Worcester, who is on the research team studying the functionally cured baby. She looked at five people who were started on ARVs before they were three months old in the mid-1990s and found that four have neither detectable virus nor HIV antibodies in their bloodstreams. Luzuriaga told Nature Medicine that “it may be reasonable to consider a trial off therapy for these kids.”

To read the Nature Medicine article, click here.

Search: functional cure, HIV, baby, infant, child, Nature Medicine, Mississippi, International Maternal Pediatric Adolescent AIDS Clinical Trials, IMPAACT, 20th Conference of Retroviruses and Opportunistic Infections, CROI, Katherine Luzuriaga.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.